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M A J O R A R T I C L E
Influenza-like Illness, the Time to Seek
Healthcare, and Influenza Antiviral Receipt
During the 2010–2011 Influenza Season—
United States
Matthew Biggerstaff,1 Michael A. Jhung,1 Carrie Reed,1 Alicia M. Fry,1 Lina Balluz,2 and Lyn Finelli1
1Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, and 2Division of Behavioral
Surveillance, Public Health Surveillance and Informatics Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia
Background. Few data exist describing healthcare-seeking behaviors among persons with influenza-like illness
(ILI) or adherence to influenza antiviral treatment recommendations.
Methods. We analyzed adult responses to the Behavioral Risk Factor Surveillance System in 31 states and the
District of Columbia (DC) and pediatric responses in 25 states and DC for January–April 2011 by demographics and
underlying health conditions.
Results. Among 75 088 adult and 15 649 child respondents, 8.9% and 33.9%, respectively, reported ILI. ILI was
more frequent among adults with asthma (16%), chronic obstruction pulmonary disease (COPD; 26%), diabetes
(12%), heart disease (19%), kidney disease (16%), or obesity (11%). Forty-five percent of adults and 57% of children
sought healthcare for ILI. Thirty-five percent of adults sought care ≤2 days after ILI onset. Seeking care ≤2 days was
more frequent among adults with COPD (48%) or heart disease (55%). Among adults with a self-reported physician
diagnosis of influenza, 34% received treatment with antiviral medications. The only underlying health condition with
a higher rate of treatment was diabetes (46%).
Conclusions. Adults with underlying health conditions were more likely to report ILI, but the majority did not
seek care promptly, missing opportunities for early influenza antiviral treatment.
Keywords. Healthcare-seeking behavior; influenza; influenza antiviral treatment; time to seek healthcare.
The Advisory Committee on Immunization Practices
(ACIP) recommends early, empiric treatment of influ-
enza with antiviral medications for persons at high risk
for influenza complications, including adults aged ≥65
years, and persons with chronic pulmonary or cardio-
vascular conditions, and diabetes [1]. In the United
States, there are few data describing clinician adherence
to ACIP recommendations or the tendency for persons
with influenza-like illness (ILI) to seek healthcare
promptly after illness onset [1–3]. The few studies
that have described adherence to ACIP treatment rec-
ommendations in an outpatient setting suggest that ad-
herence could be improved [4, 5].
To assess whether ACIP treatment guidelines were
followed during the 2009 influenza pandemic, the Cen-
ters for Disease Control and Prevention (CDC) utilized
a community-based telephone survey among the U.S.
population [6, 7]. Results indicated that during the
2009 pandemic, most persons at high risk for influenza
complications more frequently reported ILI and health-
care seeking but did not report increased receipt of in-
fluenza antiviral medication. The results also indicated
that certain socioeconomic and healthcare access fac-
tors (eg, unemployment, lack of insurance, financial
barriers to healthcare) may have reduced access to ap-
propriate medical treatment [6, 7].
The 2009 pandemic was associated with frequent
communications reminding those with high-risk factors
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to seek healthcare promptly and for healthcare providers to treat
them with influenza antivirals. Additionally, ACIP treatment
guidelines were updated prior to the start of the 2010–2011 in-
fluenza season and included the addition of morbid obesity as a
risk factor for severe influenza illness for the first time [1].
Therefore, the CDC repeated the telephone survey during the
2010–2011 influenza season to determine if the previous find-
ings would be consistent during a seasonal influenza epidemic
and to assess the time to seek healthcare, which was not collect-
ed in the previous survey [3]. In this report, we present the re-
sults from this survey conducted from January 2011 to April
2011 among adult respondents in 31 states and the District of
Columbia (DC) and pediatric respondents in 25 states and DC.
METHODS
The Behavioral Risk Factor Surveillance System (BRFSS) is a
state-based, random-digit-dialed telephone survey that is the
main data source for information on the prevalence of health-
risk behaviors and chronic health conditions among the
noninstitutionalized US population aged ≥18 years [8]; survey
methodology is described elsewhere [9]. The BRFSS has been
approved as exempt research by the CDC’s institutional review
board.
From 1 January 2011 to 30 April 2011, adult respondents in
31 states (states or territories using the BRFSS ILI module were
Alabama, Alaska, Arizona, California, Colorado, Connecticut,
Delaware, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana,
Maine, Maryland, Massachusetts, Minnesota, Mississippi, Mis-
souri, Montana, Nebraska, New Hampshire, New Jersey, North
Carolina, Oklahoma, Oregon, Rhode Island, South Dakota,
Utah, Virginia, and Wisconsin) and DC were interviewed
using a BRFSS ILI module that contained questions to deter-
mine recent ILI and healthcare-seeking behavior. Among adults
who sought care, additional questions were asked to determine
the time to seek care, whether an influenza diagnosis was re-
ceived, whether influenza testing was performed, and whether
influenza antiviral treatments were prescribed. We determined
the presence of ILI by asking 2 questions: “Last month, were you
ill with a fever?” and “Did you also have a cough and/or sore
throat?” Answering “yes” to both questions was classified as
ILI. We determined whether medical care was sought by asking,
“Did you visit a doctor, nurse, or other health professional for
this illness?” and when medical care was sought, by asking,
“When did you visit the doctor, nurse, or other health profes-
sional for this illness?” and giving a choice of 3 responses: (1)
“Within 2 days of getting ill,” (2) “Within 3 to 7 days of getting
ill,” or (3) “More than 7 days of getting ill.” Seeking care within
2 days of getting ill was chosen as the endpoint for prompt care
seeking because that is when influenza antivirals have shown
the most benefit and because this time point serves as the
cut-off for approved administration of influenza antivirals in
the product license [1, 10].We determined whether a clinical di-
agnosis of influenza was given by asking, “What did the doctor,
nurse, or other health professional tell you?” and giving a choice
of 2 responses: (1) “You had influenza or the flu” or (2) “You
had some other illness, but not the flu.”We determined whether
an influenza test was given by asking, “Did you have a flu test
that was positive for this illness?” and giving a choice of 3 re-
sponses: (1) “Had flu test and it was positive,” (2) “Had flu
test and it was negative,” or (3) “Did not have flu test.” Finally,
we determined whether antiviral medications were given by ask-
ing, “Did you receive Tamiflu or oseltamivir or an inhaled med-
icine called Relenza or zanamivir to treat this illness?”
We determined the presence of ILI and healthcare seeking
among children in 25 states (states using the BRFSS ILI module
for children were Alabama, Arizona, California, Connecticut,
Delaware, Georgia, Illinois, Iowa, Kansas, Louisiana, Maryland,
Massachusetts, Mississippi, Missouri, Montana, Nebraska, New
Hampshire, New Jersey, North Carolina, Oklahoma, Oregon,
Rhode Island, South Dakota, Utah, and Virginia) and DC by
asking adult respondents about their child’s illness. The time
to seek care, the clinical diagnosis, and receipt of an influenza
test or influenza antiviral medications were not ascertained for
children.
Adult respondents were evaluated by demographic character-
istics, preexisting health conditions, pregnancy, behavioral
factors, and healthcare access. Demographic characteristics
evaluated were age, sex, race or ethnicity, educational attain-
ment, and employment status. Preexisting health conditions
evaluated were asthma, chronic obstructive pulmonary disease
(COPD), diabetes, heart disease (ever having been diagnosed
with myocardial infarction, angina, or chronic heart disease),
kidney disease, arthritis, depression, disability, and the World
Health Organization body mass index classification as calculat-
ed from self-reported weight and height. The only behavioral
factor evaluated was smoking. Healthcare access questions eval-
uated were insurance status among those 18–64 years old, hav-
ing a personal doctor(s), and healthcare affordability. The
characteristics of children with ILI and healthcare seeking
were evaluated by age, sex, and race or ethnicity.
We used SAS-callable SUDAAN v.10 statistical software (Re-
search Triangle Institute, NC) to calculate population-weighted
estimates and corresponding standard errors, 95% confidence
intervals (CIs), and P values, taking into account the design
of the BRFSS sampling plan. We used linear contrasts to evalu-
ate differences in responses by age group, sex, race-ethnic cate-
gories, preexisting health conditions, behavioral factors, and
healthcare access questions. Statistical significance was set at
alpha (α)≤ 0.05. Because the age and sex distributions among
groups differed, prevalence estimates were age-adjusted using
the standard year 2000 projected US population [11].
Response rates were calculated using Council of American
Survey and Research Organizations guidelines [9]. Median
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survey response rates were calculated as the percentage of peo-
ple who completed interviews among all eligible people, includ-
ing those who were not contacted, while median cooperation
rates were calculated as the percentage of people who completed
interviews among all eligible people who were contacted.
RESULTS
Report of ILI Among Adults and Children
From January 2011 to April 2011, a total of 75 088 adults and
15 649 childrenwere interviewed using the BRFSS ILImodule. The
median state survey response rate was 53% (range, 37%–66%),
and the median cooperation rate was 77% (range, 55%–89%).
During this period, 8.9% of adults (median age, 41 years)
reported ILI in the calendar month preceding the interview
(Table 1). ILI was more frequently reported among adults who
were American Indian/Alaska Native (20%), unemployed (11%),
or unable to work (15%), or who reported current (16%) or
former (14%) asthma, COPD (26%), diabetes (12%), heart disease
(19%), kidney disease (16%), depression (16%), disability (14%),
obesity (11%), or financial barriers to care (15%) (Tables 1 and 2).
During this same period, 34% of children were reported to
have ILI (median age, 7 years); children who were in the age
groups 0–4 years old (38%) or 5–11 years old (37%) were re-
ported to have ILI more frequently, while children who were
identified as black, non-Hispanic were reported to have ILI
less frequently (27%) (Table 3).
Report of Healthcare Seeking Among Adults and Children
Among those participants who reported ILI, 45% of adults re-
ported seeking healthcare (Table 1). Healthcare seeking was sig-
nificantly more frequent among adults who were ≥65 years old
(60%), who reported COPD (62%), heart disease (59%), kidney
disease (69%), disability (50%), being obese (52%), or having
current (57%) or past (58%) asthma (Tables 1 and 2). Converse-
ly, reports of healthcare seeking were significantly less frequent
among adults who identified as American Indian/Alaska Native
(34%), were unemployed (35%), or who reported having no in-
surance (27%) or no personal doctor (38%) (Tables 1 and 2).
Among children with ILI, 57% were reported to have sought
healthcare, and children in the age groups 0–4 years old (68%)
and 5–11 years old (56%) and those who were black, non-
Hispanic (67%); or Hispanic (64%) were reported to have
sought care significantly more frequently (Table 3).
Time to Seek Healthcare Among Adults
Of adult healthcare seekers, 35% sought care for ILI within 2
days and 47% within 3–7 days of illness onset (Table 4).
Among the medical conditions evaluated, only adults with
COPD (48%) or heart disease (55%) were significantly more
likely to seek care within 2 days (Table 5). Adults who were un-
employed (25%), unable to work (27%), or who reported
diabetes (23%), kidney disease (22%), or no insurance (23%)
were significantly less likely to seek care within 2 days (Tables 4
and 5).
Report of Influenza Diagnosis and Influenza Testing Among
Adults
Among adults who reported ILI and sought healthcare, 26% re-
ported a clinical diagnosis of influenza, and 27% reported re-
ceiving an influenza test. Reports of receiving a clinical
diagnosis of influenza (19%) or an influenza diagnostic test
(11%) were less frequent among adults who sought healthcare
≥7 days from illness onset (Supplementary Tables 1 and 2).
Antiviral Medication Receipt Among Adults Diagnosed With
Influenza
Among adults who reported ILI, sought healthcare, and were
diagnosed with influenza, 34% reported receiving an influenza
antiviral medication (Table 1). Influenza antiviral medication
receipt did not significantly differ by most of the characteristics
evaluated with sufficient numbers for reliable estimates, includ-
ing most high-risk conditions in adults (Tables 1 and 2). Receipt
of influenza antiviral medication was significantly higher
among persons with diabetes (46%) but was significantly
lower among adults who were disabled (18%) (Tables 1 and
2). Patients who received influenza antiviral medication (55%)
were significantly more likely to have reported seeking health-
care within 2 days than those who did not receive influenza
antivirals (35%) (Table 5).
DISCUSSION
To our knowledge, this study represents the largest telephone
survey conducted in the United States that describes healthcare
seeking and outpatient use of antiviral medications among
adults with high-risk conditions during a regular influenza sea-
son. We found that most adults with underlying medical con-
ditions had higher proportions of self-reported ILI but were not
more likely to seek care within 2 days, except those with COPD
and heart disease, or to be treated with influenza antiviral med-
ications. However, we found that prompt healthcare seeking was
associated with increased receipt of antiviral medications. Our
findings highlight the need to educate patients at high risk for
influenza complications to seek care early, to educate physicians
about the benefits of influenza antiviral treatment among high-
risk patients, and to better understand the social, medical, and
economic barriers that may prevent the use of influenza antivi-
ral treatment that is consistent with ACIP recommendations
during a seasonal influenza epidemic.
During the 2010–2011 influenza season, American Indian/
Alaska Native adults and those reporting asthma, heart disease,
and disability were more likely to report ILI, a finding consistent
with risk factors for ILI identified during the 2009 pandemic
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[6, 7]. Additionally, adults reporting COPD, kidney disease, ar-
thritis, and depression (conditions that were not ascertained
during the previous BRFSS pandemic survey) were also more
likely to report ILI. The consistency of these results may indicate
that certain ACIP high-risk conditions, which are already
known to confer an increased risk for influenza complications,
may also increase the risk for the acquisition of influenza or
other respiratory virus infections [12–17]. Alternately, persons
with high-risk conditions in this study may have just been
more likely to recall symptoms consistent with influenza illness.
No study has systematically assessed the risk for acquiring influ-
enza by the presence or absence of ACIP high-risk conditions,
and further research is needed before any assessment of differ-
ential risk can be made.
Only a third of respondents sought care within 2 days of ill-
ness onset, when influenza antiviral medications are most effec-
tive, and prompt healthcare seeking was associated with
increased receipt of antiviral medications in this survey. Howev-
er, more than 80% of patients sought care within 7 days when
antivirals may have some benefit [1, 18, 19]. Those without in-
surance and those who are unemployed or unable to work were
significantly more likely to either delay care or not seek care,
which may place them at higher risk for severe outcomes
from influenza. Efforts to identify and reduce the barriers
Table 1. Reported ILI in the Calendar Month Preceding Interview, Healthcare Seeking for ILI, and Influenza Antiviral Treatment Among
Those Who Sought Healthcare and Were Diagnosed With Influenza, Among Adults (≥18 Years Old), by Selected Demographics, 1 January
2011–30 April 2011
Characteristics
Reported ILI Sought Healthcare for ILI
Antiviral Treatment Among
Those Who Sought
Healthcare and Were
Clinically Diagnosed With
Influenza
n % Yes 95% CI n % Yes 95% CI n % Yes 95% CI
All respondents 75 088 8.9 8.2–9.6 5763 45.2 41.3–49.2 512 34.1 22.8–47.6
Age group, in yearsa
18–49 23 208 10.6* 9.5–11.8 2390 42.7* 37.4–48.1 208 37.2 22.0–55.5
50–64 25 547 7.8* 7.1–8.5 2117 47.2* 42.7–51.9 181 28.9 18.2–42.6
≥65b 25 730 4.5 4.0–5.1 1224 60.0 53.6–66.1 123 19.2 11.5–30.4
Sexa
Male 1842 8.1* 7.0–9.4 1840 34.7* 28.8–41.1 150 37.8 20.3–59.2
Femaleb 3926 9.6 8.9–10.4 3923 53.8 49.7–57.8 362 31.6 18.3–48.7
Race or ethnic group
White, non-Hispanicb 60 784 8.8 8.2–9.4 4522 47.0 44.0–50.1 354 22.9 16.1–31.4
Black, non-Hispanic 6154 7.8 5.5–11.0 408 52.5 42.1–62.6 57 52.3* 38.8–65.5
Hispanic 3346 9.4 7.4–11.8 340 43.6 32.7–55.0 54 45.3 25.3–66.9
American Indian/Alaska Native 1167 19.5* 12.3–29.5 146 33.5* 23.7–45.0 16 38.7c 18.3–64.2
Other race, NH 2425 10.7 7.3–15.5 263 50.0 36.9–63.2 26 10.7*c 4.6–22.9
Level of education
Less than high school 6307 11.0* 8.9–13.7 580 48.3 40.1–56.6 64 39.1 28.7–50.7
High school graduate 22 335 9.7 8.2–11.4 1644 50.3 44.1–56.4 173 26.7 14.6–43.6
Some college/college graduateb 45 694 8.2 7.5–8.9 3499 43.8 40.1–47.6 273 40.1 28.8–52.5
Employment status
Employedb 36 323 8.2 7.4–9.0 2783 44.1 39.4–48.9 237 33.6 21.7–48.1
Unemployed 4158 11.1* 9.0–13.6 411 34.7* 27.3–42.9 34 27.1c 12.8–48.6
Unable to work 5147 15.2* 13.1–17.7 907 57.3* 48.7–65.5 90 15.5* 8.7–26.2
Homemaker 5164 5.7 3.6–8.8 364 37.2 21.8–55.6 36 35.7c 17.9–58.5
Student 1057 8.6 5.3–13.6 130 45.1 28.2–63.2 17 46.0c 36.8–55.5
Retired 22 459 10.5 5.6–18.7 1120 49.3 42.2–56.4 98 18.8 12.3–27.6
Abbreviations: CI, confidence interval; ILI, influenza-like illness.
a Estimate not age and sex adjusted because variable includes an age or sex component.
b Reference group for statistical comparison.
c Estimate might be unreliable because the relative standard error is ≥30% of estimate or the unweighted sample size is <50. Caution should be used when
interpreting this estimate.
*P < .05 compared with reference group.
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Table 2. Reported ILI in the Calendar Month Preceding Interview, Healthcare Seeking for ILI, and Influenza Antiviral Treatment Among
Those Who Sought Healthcare and Were Diagnosed With Influenza, Among Adults (≥18 Years Old), by Selected Medical Conditions and
Other Characteristics, 1 January 2011–30 April 2011
Characteristics
Reported ILI Sought Healthcare for ILI
Antiviral Treatment Among
Those Who Sought
Healthcare and Were
Clinically Diagnosed With
Influenza
n % 95% CI n % 95% CI n % 95% CI
ACIP high-risk medical conditions
No ACIP conditiona 52 335 7.6 6.8–8.4 3245 41.5 37.6–45.6 272 36.6 23.0–52.6
Asthma
Current 6493 16.0* 13.9–18.5 1124 56.6* 48.8–64.0 112 26.7b 12.2–48.8
Former 2447 13.5* 9.5–18.8 250 57.6* 46.9–67.6 16 8.6*,b 6.4–11.5
Nevera 65 102 8.0 7.2–8.8 4294 43.4 39.8–47.1 381 39.4 27.3–52.9
COPD
Yes 5752 25.9* 21.6–30.7 1096 61.8* 52.7–70.1 106 18.7 10.5–31.3
Noa 68 393 8.2 7.5–9.0 4593 43.2 39.7–46.7 400 34.6 23.5–47.7
Diabetes
Yes 9353 11.7* 9.2–14.7 909 55.2 44.1–65.8 88 46.3* 38.7–54.1
Noa 65 032 8.8 8.1–9.6 4805 45.2 41.8–48.6 422 31.1 20.4–44.4
Heart disease
Yes 6987 19.3* 14.2–25.7 696 58.8* 45.6–70.9 80 29.1b 12.6–53.9
Noa 66 866 8.6 7.9–9.4 4965 44.7 41.4–48.2 428 34.3 23.5–47.0
Kidney disease
Yes 2310 15.9* 10.7–22.9 285 68.7* 54.7–79.9 38 12.7*,b 6.4–23.4
Noa 71 949 8.9 8.2–9.6 5407 45.6 42.3–48.9 472 34.4 23.4–47.4
≥1 ACIP condition 22 141 14.7* 13.0–16.5 2485 52.7* 47.2–58.2 240 24.6 13.0–41.5
Other medical conditions
Arthritis
Yes 26 209 14.2* 12.5–16.1 2515 51.5* 46.0–56.9 244 18.6 11.3–29.1
Noa 47 877 7.9 7.1–8.7 3177 42.7 38.7–46.7 264 34.1 21.9–48.7
Depression
Yes 12 804 15.6* 13.1–18.4 1862 46.3 40.4–52.3 168 19.1* 12.3–28.6
Noa 61 371 7.7 7.0–8.5 3839 46.4 42.6–50.4 344 36.7 23.8–51.7
Disability
Yes 23 027 14.3* 12.4–16.4 2624 50.1* 44.2–56.0 235 17.7* 10.1–29.1
Noa 51 158 7.4 6.7–8.2 3080 42.7 38.6–46.8 275 39.9 26.4–55.2
Pregnancyc
Yes 374 7.3b 3.9–13.4 33 52.3b 24.4–78.8 2 N/A N/A
Noa 10 187 11.4 10.0–12.9 1162 54.1 47.6–60.5 111 N/A N/A
Weight status
Underweight 1099 12.0 7.3–18.9 105 43.3 30.5–57.1 9 15.8b 2.7–55.6
Normal Weighta 23 709 8.9 7.4–10.7 1541 39.0 33.7–44.6 133 31.2 18.1–48.2
Overweight 26 173 7.7 6.9–8.7 1856 47.6* 42.2–53.1 165 28.2 17.1–42.9
Obese 20 062 11.1* 9.9–12.5 1975 51.9* 46.4–57.4 184 37.8 25.2–52.3
Health status
Fair or poor health 14 216 14.4* 12.6–16.5 1922 56.8* 50.0–63.4 184 35.8 18.5–57.8
Good, very good, or excellent healtha 59 978 7.9 7.2–8.7 3788 42.1 38.4–45.8 326 32.4 21.4–45.7
Smoking status
Current smoker 11 258 10.8* 9.6–12.1 1253 45.1 40.0–50.3 102 22.5b 11.9–38.3
Former smoker 22 840 9.1 8–10.4 1723 46.8 41.2–52.4 135 31.6 20.7–45.0
Never smokeda 40 049 8.4 7.4–9.5 2735 45.6 40.7–50.6 273 36.3 22.0–53.4
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associated with missed or delayed healthcare seeking among the
unemployed and those unable to work or without health
insurance are needed to ensure that access to effective antiviral
treatment is available to this population.
Table 2 continued.
Characteristics
Reported ILI Sought Healthcare for ILI
Antiviral Treatment Among
Those Who Sought
Healthcare and Were
Clinically Diagnosed With
Influenza
n % 95% CI n % 95% CI n % 95% CI
Healthcare access
Insurance among 18–64 y oldsc
Yesa 42 403 9.5 8.6–10.4 3836 47.7 42.9–52.5 337 32.6 20.6–47.4
No 6239 11.3 9.2–13.7 660 27.4* 19.5–37.1 52 48.0b 20.6–47.4
Personal doctor
Yesa 65 753 9.3 8.4–10.1 5025 48.4 44.9–52.0 476 34.4 24.5–45.9
No 8548 8.3 6.9–10.1 692 37.9* 29.6–46.8 35 25.0b 11.5–46.0
Financial barrier to care
Yes 7905 14.9* 13.0–17.1 1237 42.9 36.9–49.0 109 33.9 18.5–53.7
Noa 66 425 7.9 7.1–8.7 4479 47.5 43.7–51.4 401 31.9 20.3–46.3
Abbreviations: ACIP, Advisory Committee on Immunization Practices; CI, confidence interval; COPD, chronic obstruction pulmonary disease; ILI, influenza-like
illness; N/A, sample size too small to estimate value.
a Reference group for statistical comparison.
b Estimate might be unreliable because the relative standard error is ≥30% of estimate or the unweighted sample size is <50. Caution should be used when
interpreting this estimate.
c Estimate not age and sex adjusted because variable includes an age or sex component.
*P < .05 compared with reference group.
Table 3. Percentage of Children (<18 Years Old) Reported to Have ILI in the Calendar Month Preceding Interview and to Have Sought
Healthcare for ILI, by Selected Demographics, 1 January 2011–30 April 2011
Characteristics
Reported ILI Sought Healthcare for ILI
n % Yes 95% CI n % Yes 95% CI
All respondents 15 649 33.9 32.4–35.5 5113 56.6 53.8–59.5
Age group, in yearsa
0–4 1330 38.1* 34.9–41.4 910 68.0* 62.8–72.7
5–11 1879 37.3* 34.7–40.0 1067 56.3* 51.7–60.9
12–17b 1931 27.1 24.9–29.5 943 45.6 40.9–50.5
Sexa
Male 2612 33.4 31.3–35.6 1468 54.1 50.1–58.1
Femaleb 2502 34.8 32.5–37.1 1434 58.6 54.5–62.6
Race or ethnic group
White, non-Hispanicb 10 726 36.7 35.0–38.5 3657 51.1 48.0–54.2
Black, non-Hispanic 1765 27.1* 23.4–31.2 436 67.1* 59.1–74.3
Hispanic 1647 32.9 28.6–37.4 532 64.1* 55.9–71.5
American Indian/Alaska Native 383 35.9 26.1–47.0 136 64.3 47.4–78.2
Other race, NH 919 32.9 27.6–38.6 291 51.1 42.1–59.9
Abbreviations: CI, confidence interval; ILI, influenza-like illness.
a Estimate not age and sex adjusted because variable includes an age or sex component.
b Reference group for statistical comparison.
*P < .05 compared with reference group.
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Thirty-four percent of respondents who received an influen-
za diagnosis reported receiving an influenza antiviral medica-
tion. This represents a large increase from the 14%–19% that
reported receiving an influenza antiviral medication during
the 2006–2007 influenza season, and is similar to the 36% re-
ported during the 2009 pandemic [6, 20]. The reason for this
increase is unclear but may be the result of expansion of
ACIP recommendations for influenza antiviral treatment from
2008 [21] to the 2009 pandemic [22], or an increasing number
of publications and communications describing the benefits of
early empiric treatment with influenza antiviral medications,
especially during and after the 2009 pandemic. However, chal-
lenges in increasing the uptake of influenza antiviral medica-
tions remain. This study found that groups at increased risk
for severe illness (most persons reporting any chronic condition
and those ≥65 years) have similar or lower rates of antiviral
medication receipt when compared with younger persons or
persons with no ACIP high-risk conditions. These results are
similar to those seen during the 2009 pandemic and the
2006–2007 influenza season, and suggest that more work is
needed to improve treatment rates among those most vulnera-
ble to influenza complications. This should include efforts to
better understand the effect of reduced healthcare access and af-
fordability on receipt of appropriate and timely influenza anti-
viral treatment as well as the impact that a lack of physician
education may have.
Our results also reinforce the finding that telephone surveys,
which traditionally have not been used to monitor morbidity
from influenza, may provide an efficient survey method for
monitoring the burden of disease from influenza and adherence
to treatment guidelines. As such, they may also help better de-
fine the assumptions of mathematical models describing the
Table 4. Time From ILI Onset to Healthcare Seeking, Among Adults (≥18 Years Old) Who Reported ILI and Sought Healthcare, by
Selected Demographics, 1 January 2010–30 April 2011
Characteristics n
≤2 d 3–7 d ≥8 d
% Yes 95% CI % Yes 95% CI % Yes 95% CI
All respondents 2996 34.6 29.9–39.6 47.4 42.6–52.2 18.0 15.2–21.2
Age group, in yearsa
18–49 1165 37.7* 31.0–44.9 46.6 39.8–53.6 15.7* 12.3–19.9
50–64 1054 29.0 24.1–34.5 50.2 44.2–56.2 20.8 16.4–26.0
≥65b 761 27.8 22.6–33.6 47.4 40.5–54.4 24.8 17.6–33.8
Sexa
Male 819 34.0 27.0–41.9 48.8 40.6–57.1 17.2 12.9–22.6
Femaleb 2177 34.9 28.9–41.4 46.7 40.8–52.6 18.4 15.0–22.5
Race or ethnic group
White, non-Hispanicb 2340 33.6 29.3–38.2 46.8 42.4–51.2 19.6 16.7–23.0
Black, non-Hispanic 228 30.5 19.4–44.4 48.5 33.4–64.0 21.0 13.5–31.2
Hispanic 183 30.4 20.4–42.6 60.5* 48.1–71.7 9.1* 5.0–15.9
American Indian/Alaska Native 83 43.4 25.6–62.9 49.2 30.9–67.7 7.5*,1 3.3–16.1
Other race, NH 124 57.2* 40.1–72.8 22.9* 12.5–38.1 19.91 10.6–34.4
Level of education
Less than high school 332 31.4 21.2–43.9 52.4 38.1–66.4 16.11 7.5–31.5
High school graduate 922 34.3 25.6–44.3 46.0 37.1–55.2 19.6 15.0–25.4
Some college/college graduateb 1723 33.8 29.0–38.9 48.6 43.0–54.2 17.7 14.5–21.4
Employment status
Employedb 1344 38.8 32.9–45.0 45.8 39.3–52.3 15.5 12.4–19.1
Unemployed 182 25.1* 16.4–36.3 54.6 42.4–66.2 20.3 12.8–30.7
Unable to work 548 27.4* 19.5–37.0 43.0 34.4–52.1 29.6* 19.2–42.7
Homemaker 188 18.5* 12.3–27.0 71.7* 64.0–78.3 9.8* 6.3–15.1
Student 67 43.1 25.3–62.9 51.1 33.5–68.5 5.7*,1 1.6–18.7
Retired 647 10.2* 7.8–13.3 78.5* 72.2–83.6 11.3 7.2–17.3
Abbreviations: CI, confidence interval; ILI, influenza-like illness.
a Estimate not age and sex adjusted because variable includes an age or sex component.
b Reference group for statistical comparison.
*P < .05 compared with reference group.
1Estimate might be unreliable because the relative standard error is ≥30% of estimate or the unweighted sample size is <50. Caution should be used when
interpreting this estimate.
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Table 5. Time From ILI Onset to Healthcare Seeking, Among Adults (≥18 Years Old) Who Reported ILI and Sought Healthcare, by
Selected Medical Conditions and Other Characteristics, 1 January 2010–30 April 2011
Characteristics n
≤2 d 3–7 d ≥8 d
% Yes 95% CI % Yes 95% CI % Yes 95% CI
ACIP high-risk medical conditions
No ACIP conditiona 1473 33.2 27.7–39.1 51.3 45.0–57.5 15.6 12.5–19.2
Asthma
Current 722 30.1 21.4–40.6 50.7 40.5–60.7 19.2 14.4–25.2
Former 143 26.7 14.5–44.0 46.3 31.0–62.4 27.0 17.2–39.5
Nevera 2085 35.5 30.4–41.0 47.9 42.3–53.6 16.6 13.6–20.1
COPD
Yes 751 47.7* 40.1–55.4 33.4* 27.3–40.2 18.8 13.7–25.3
Noa 2199 31.8 27.3–36.7 50.8 45.6–56.0 17.4 14.4–20.9
Diabetes
Yes 544 22.8* 16.7–30.4 56.5 44.1–68.1 20.7 12.5–32.1
Noa 2428 34.6 29.8–39.8 47.3 42.1–52.6 18.0 15.1–21.4
Heart disease
Yes 447 54.5* 43.4–65.1 33.6* 24.4–44.2 12.0* 8.0–17.6
Noa 2494 32.4 27.9–37.1 49.1 44.1–54.2 18.5 15.5–21.9
Kidney disease
Yes 186 21.6* 13.3–33.1 31.1* 20.8–43.7 47.3* 32.3–62.8
Noa 2771 34.6 29.9–39.6 48.5 43.5–53.6 16.9 14.3–19.7
≥1 ACIP condition 1507 35.0 27.6–43.2 42.8 35.6–50.2 22.2 17.0–28.6
Other medical conditions
Arthritis
Yes 1472 35.1 27.4–43.6 42.8 35.7–50.2 22.1 15.5–30.6
Noa 1489 36.0 30.3–42.1 47.7 41.6–53.8 16.3 13.2–20.0
Depression
Yes 1046 31.9 25.0–39.8 43.7 36.8–50.9 24.3* 18.2–31.8
Noa 1921 34.8 29.2–40.9 49.4 43.3–55.5 15.8 12.9–19.1
Disability
Yes 1520 33.6 26.1–42.0 45.7 38.5–53.1 20.7 15.4–27.3
Noa 1449 34.5 28.8–40.7 49.2 42.9–55.5 16.3 13.2–20.1
Weight status
Underweight 57 30.1 16.7–48.0 65.1* 50.0–77.6 4.8*,1 1.6–13.8
Normal Weighta 739 29.2 21.7–38.0 48.3 40.0–56.6 22.6 17.3–28.8
Overweight 960 34.4 27.5–42.0 48.6 40.8–56.5 17.0 12.6–22.6
Obese 1089 35.5 28.7–43.0 49.0 41.4–56.7 15.5* 11.8–20.0
Health status
Fair or poor health 1162 28.6 22.2–35.9 50.4 41.6–59.1 21.1 15.1–28.6
Good, very good, or excellent healtha 1808 35.6 30.0–41.5 47.3 41.5–53.2 17.1 14.1–20.5
Smoking status
Current smoker 636 32.5 25.7–40.2 43.6 35.9–51.7 23.8 16.5–33.1
Former smoker 913 34.8 27.1–43.4 45.9 37.2–55.0 19.3 14.5–25.2
Never smokeda 1419 33.7 27.1–40.9 51.1 43.9–58.3 15.2 12.1–19.0
Healthcare access
Insurance among 18–64 y oldsb
Yesa 2008 37.3 31.7–43.2 45.3 39.8–50.9 17.4 14.3–21.1
No 207 22.9* 13.1–36.9 63.1* 47.3–76.5 14.0 8.0–23.2
Personal doctor
Yesa 2757 32.9 28.7–37.3 48.9 44.0–53.7 18.3 15.3–21.6
No 216 37.9 23.8–54.4 43.9 29.0–60.0 18.2 10.5–29.6
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transmission and spread of influenza. Because data describing
differences in healthcare seeking, time to seek healthcare, and
antiviral treatment by demographic groups have been largely
unavailable, mathematical models frequently utilized assump-
tions that may not have been validated with epidemiological
or laboratory data from seasonal or pandemic influenza [23].
The results of this study, including the important behavioral in-
formation, may help provide some of this missing information.
The methodology in this report is subject to several limita-
tions. First, the positive predictive value of the ILI definition
used in this study likely varied over time as the prevalence of
influenza illness fluctuated throughout the influenza season
[6, 7]. This may have caused respondents to self-report ILI
that was not influenza, particularly during periods of low influ-
enza activity. Second, data in this study are self-reported and
subject to recall and social desirability bias. Therefore, the re-
port of a clinical diagnosis of influenza or receiving an influenza
diagnostic test or antiviral medication has not been verified and
may represent the receipt of diagnoses other than influenza or
noninfluenza clinical tests or treatments (eg, antibiotics). How-
ever, we would expect any potential misclassification to be sim-
ilar for high-risk and non-high-risk respondents. Third,
because the percentage of respondents reporting a positive in-
fluenza test can be influenced by the duration from illness onset
to healthcare encounter and the sensitivity of the type of influ-
enza diagnostic test used, the proportion of respondents report-
ing a positive influenza test should not be interpreted as the
percentage of confirmed influenza [24–26]. Fourth, we only as-
sessed risk factors available in the BRFSS during the 2010–2011
influenza season. Therefore, because some known risk factors
for influenza complications were not included (eg, persons
with hepatic, neurologic/neuromuscular, or hematologic disor-
ders, or persons with immunosuppression), some persons with
high-risk conditions could be misclassified as having no high-
risk medical conditions. Fifth, BRFSS data are collected only
from households with a landline telephone, and our study is
subject to selection bias resulting from exclusion of households
with only cellular phones [27]. Finally, the BRFSS is a house-
hold survey that does not collect information from persons in
institutions, nursing homes, long-term care facilities, and cor-
rectional institutions. Therefore, the results presented in this
analysis do not generalize to these populations.
During the influenza season following the 2009 pandemic,
most adults with underlying medical conditions had higher
proportions of self-reported ILI but were not more likely to
seek healthcare promptly than individuals without these condi-
tions. A third of persons who received a diagnosis of influenza
during a medical visit reported receiving treatment with
Table 5 continued.
Characteristics n
≤2 d 3–7 d ≥8 d
% Yes 95% CI % Yes 95% CI % Yes 95% CI
Financial barrier to care
Yes 579 27.4 19.9–36.3 53.5 43.4–63.3 19.1 13.8–25.9
Noa 2394 36.8 31.5–42.5 45.9 40.4–51.5 17.3 14.2–20.8
Influenza diagnosis
Yes 566 40.0 30.7–50.0 47.8 37.7–58.0 12.3* 7.5–19.3
Noa 2279 33.9 29.2–38.9 46.9 41.9–52.0 19.3 16.3–22.7
Influenza testing
Tested for influenza
Yes 638 42.2 34.4–50.5 50.4 42.1–58.7 7.4* 4.5–11.9
Noa 1966 32.8 26.8–39.3 46.5 40.2–53.0 20.7 17.1–24.9
Tested positive influenza
Yes 248 38.8 29.4–49.1 54.1 43.0–64.9 7.01 3.7–12.9
Noa 390 43.8 34.7–53.3 48.1 38.6–57.7 8.11 4.3–14.7
Influenza antivirals
Yes 171 54.5* 42.2–66.3 39.2 27.7–52.0 6.3 2.8–13.6
Noa 337 34.5 21.6–50.1 49.5 34.8–64.3 16.0 8.8–27.5
Abbreviations: ACIP, Advisory Committee on Immunization Practices; CI, confidence interval; COPD, chronic obstruction pulmonary disease; ILI, influenza-like
illness.
a Reference group for statistical comparison.
b Estimate not age and sex adjusted because variable includes an age or sex component.
1Estimate might be unreliable because the relative standard error is ≥30% of estimate or the unweighted sample size is < 50. Caution should be used when
interpreting this estimate.
*P < .05 compared with reference group.
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antiviral medication, and the rates of antiviral treatment were
not significantly different among those with and without any
high-risk condition. Further efforts are needed to educate per-
sons at high risk to seek healthcare early and to identify reasons
why persons at high risk are not receiving influenza antivirals.
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Supplemental Table 1–Report of influenza diagnosis and influenza diagnostic test among those with 
influenza-like illness who sought health care, adults (≥18 years old), by selected demographics, January 1, 
2011–April 30, 2011. 
 
Clinical diagnosis of 
influenza among those who 
sought healthcare for ILI 
Reported influenza test 
among those who sought 
healthcare for ILI 
Characteristics n % Yes 95% CI n % Yes 95% CI 
 All respondents 2884 25.7 20.7–31.5 2638 26.9 22.8–31.4 
Age group, 
in years
a
 
18–49 1130 27.4 20.3–35.9 1032 26.9
*
 21.4–33.2 
50–64 1017 24.1 18.7–30.3 933 31.2
*
 24.8–38.4 
65+
#
 721 19.5 15.1–24.9 661 18.1 13.5–23.8 
Sex
a
 
Male 775 30.9 22.4–41.0 723 30.8 23.3–39.4 
Female
#
 2109 23.1 17.1–30.4 1915 24.8 20.3–30.1 
Race or 
ethnic group 
White, non-Hispanic
#
 2246 17.6 14.0–21.8 2074 24.6 20.8–28.8 
Black, non-Hispanic 221 30.4
*
 20.8–42.1 205 51.5
*
 37.5–65.3 
Hispanic 179 51.3
*
 38.6–63.9 146 26.7 16.5–40.3 
American Indian/Alaska 
Native 
81 19.4 11.8–30.2 72 48.4
*
 31.6–65.5 
Other race, NH 120 47.4 32.0–63.4 110 17.3
1
 7.8–34.3 
Level of 
education 
Less than high school 315 24.6 13.2–41.3 299 31.3 20.1–45.2 
High school graduate 876 33.8 24.4–44.7 809 21.1 15.8–27.6 
Some college/college 
graduate
#
 
1674 20.6 16.2–25.7 1515 31.7 26.1–37.8 
Employment 
status 
Employed
#
 1309 23.4 17.9–30.1 1200 19.8 15.7–24.7 
Unemployed 172 31.0 19.3–45.7 159 23.7 14.5–36.2 
Unable to work 523 29.3 18.2–43.6 476 27.7 20.8–35.9 
Homemaker 178 16.8 10.6–25.5 163 20.5 14.0–28.9 
Student 67 46.7
*
 28.4–66.0 63 40.5
*
 25.8–57.3 
Retired 615 26.3
1
 12.1–48.1 561 32.3 18.0–51.0 
a
Estimate not age and sex adjusted since variable includes an age or sex component 
# Reference group for statistical comparison  
*P <0.05 compared with reference group 
1
Estimate might be unreliable because the relative standard error ≥30% of estimate or the un-
weighted sample size is <50. Caution should be used when interpreting this estimate. 
 
Supplemental Table 2– Report of influenza diagnosis and influenza diagnostic test among those with 
influenza-like illness who sought health care, adults (≥18 years old), by selected medical conditions and 
other characteristics, January 1, 2011–April 30, 2011. 
 
Clinical diagnosis of 
influenza among those who 
sought healthcare for ILI 
Reported influenza test 
among those who sought 
healthcare for ILI 
Characteristics n % Yes 95% CI n % Yes 95% CI 
ACIP 
high-risk 
medical 
conditions 
No ACIP condition
#
 1384 28.1 21.5–35.7 1266 26.0 20.7–32.1 
Asthma 
Current 701 27.5 18.1–39.5 624 34.6 25.0–45.7 
Former 137 23.9
1
 11.2–43.9 126 12.6
*
 7.1–21.5 
Never
#
 2004 26.2 20.7–32.4 1852 27.3 22.5–32.7 
COPD  
Yes 722 17.4 9.5–29.6 658 24.3 17.7–32.5 
No
#
 2120 28.0 22.4–34.4 1940 27.3 22.6–32.6 
Diabetes 
Yes 518 30.2 16.0–49.4 478 32.3 19.6–48.4 
No
#
 2342 26.2 20.9–32.3 2140 25.9 21.5–30.8 
Heart disease 
Yes 417 15.8
*
 10.9–22.4 384 30.4 19.4–44.3 
No
#
 2417 27.0 21.7–33.0 2213 26.2 21.8–31.1 
Kidney disease 
Yes 173 40.4 23.2–60.3 163 26.4 16.4–39.7 
No
#
 2674 25.9 20.8–31.8 2440 26.9 22.7–31.7 
≥1 ACIP condition 1484 23.7 16.9–32.3 1360 29.3 22.5–37.2 
Other 
medical 
conditions 
Arthritis 
Yes 1412 25.1 17.4–34.8 1304 28.7 22.0–36.4 
No
#
 1437 26.2 20.3–33.1 1302 27.5 22.2–33.6 
Depression 
Yes 1003 24.4 16.9–33.7 903 25.2 19.3–32.3 
No
#
 1852 27.3 21.2–34.5 1713 27.2 22.1–33.0 
Disability 
Yes 1460 21.4 15.5–28.8 1329 28.6 22.4–35.7 
No
#
 1397 28.6 22.1–36.1 1287 25.6 20.3–31.7 
Weight 
status 
Underweight 54 8.5
*1
 4.0–17.2 47 4.7
*1
 1.9–10.9 
Normal Weight
#
 710 27.9 20.0–37.4 641 30.3 21.7–40.6 
Overweight 918 26.9 19.6–35.7 855 24.6 18.9–31.3 
Obese 1056 22.4 15.7–31.0 967 27.4 21.2–34.6 
 
Health 
status 
Fair or poor health  1106 29.6 20.4–40.8 1017 24.1 18.1–31.4 
Good, very good, or 1752 25.4 19.6–32.1 1603 27.7 22.6–33.6 
excellent health
#
 
Smoking 
status 
Current smoker 609 28.7 20.5–38.6 560 30.3 22.9–38.8 
Former smoker 870 14.8
*
 10.3–20.8 793 29.1 20.8–38.9 
Never smoked
#
 1381 30.9 23.5–39.4 1267 25.9 20.5–32.0 
Healthcare 
access 
Insurance 
among 18–64 
year olds
a
 
Yes
#
 1942 25.0 19.2–31.9 191 25.5 13.5–42.8 
No 201 38.2 21.5–58.3 1771 28.4 23.6–33.7 
Personal doctor Yes
#
 2658 24.9 20.1–30.4 2425 28.9 24.4–33.9 
No 203 32.5 18.4–50.8 196 22.0 13.8–33.2 
Financial 
barrier to care 
Yes 553 33.7 24.0–45.2 518 25.8 18.3–35.1 
No
#
 2307 24.8 19.1–31.6 2104 27.2 22.4–32.5 
Time to 
seek 
healthcare 
Within 2 days from onset
#
 904 29.3 22.1–37.6 830 32.2 25.9–39.2 
3–7 days from onset 1364 26.9 19.7–35.5 1253 28.5 21.8–36.2 
>7 days from onset 577 19.1 11.4–30.1 521 11.1
*
 6.6–18.2 
a
Estimate not age and sex adjusted since variable includes an age or sex component 
# Reference group for statistical comparison  
*P <0.05 compared with reference group 
1
 Estimate might be unreliable because the relative standard error ≥30% of estimate or the un-
weighted sample size is <50. Caution should be used when interpreting this estimate. 
 
 
 
